Biomed Central Ltd

SHERPA: Unknown

People

  1. D'Angelo
    D'Angelo
  2. Tap
    Tap
  3. Kelly
    Kelly
  4. Chi
    Chi
  5. Antonescu
    Antonescu
  6. Gounder
    Gounder
  7. Richards
    Richards
  8. Avutu
    Avutu
  9. Barker
    Barker
  10. Bradic
    Bradic

Groups

  1. Department of Medicine (32)
  2. Sarcoma Service (32)
  3. Solid Tumor Oncology Division (32)
  4. Hematologic Malignancies, Division of (24)
  5. GSK Faculty (5)
  6. Tow Center for Developmental Oncology (TCDO) (5)
  7. Human Oncology and Pathogenesis Program (4)
  8. Department of Pathology and Laboratory Medicine (2)
  9. Melanoma Disease Management Team (2)
  10. Weinberg Fellows (2)
Search Within
  1. "Sarcoma Service"
Formats
  1. Journal Article (15)
  2. Meeting Abstract (14)
  3. Guidelines (1)
  4. Research Letter (1)
  5. Review (1)
Groups
  1. Department of Medicine (32)
  2. Sarcoma Service (32)
  3. Solid Tumor Oncology Division (32)
  4. Hematologic Malignancies, Division of (24)
  5. GSK Faculty (5)
  6. Tow Center for Developmental Oncology (TCDO) (5)

More Groups

People
  1. Sandra D'Angelo (24)
  2. William Tap (6)
  3. Ciara Kelly (5)
  4. Ping Chi (4)
  5. Allison Richards (2)
  6. Cristina Antonescu (2)

More People

Years
  1. 2024 (3)
  2. 2022 (6)
  3. 2021 (4)
  4. 2020 (7)
  5. 2019 (5)
  6. 2018 (4)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (25)
  2. Journal of Hematology & Oncology (3)
  3. BMC Cancer (2)
  4. Cardio-Oncology (1)
  5. Journal of Experimental & Clinical Cancer Research (1)

Results (32)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • First-line avelumab in a cohort of 116 patients with metastatic Merkel cell carcinoma (JAVELIN Merkel 200): Primary and biomarker analyses of a phase II study
    Journal Article

    D'Angelo, S. P.; Lebbé, C.; Mortier, L.; Brohl, A. S.; Fazio, N.; Grob, J. J.; Prinzi, N.; Hanna, G. J.; Hassel, J. C.; Kiecker, F.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Selinexor versus doxorubicin in dedifferentiated liposarcoma PDXs: Evidence of greater activity and apoptotic response dependent on p53 nuclear accumulation and survivin down‐regulation
    Journal Article

    Zuco, V.; Pasquali, S.; Tortoreto, M.; Brich, S.; Percio, S.; Dagrada, G. P.; Colombo, C.; Sanfilippo, R.; Lauricella, C.; Gounder, M.; more...
    Journal of Experimental & Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • The management of metastatic GIST: Current standard and investigational therapeutics
    Review

    Kelly, C. M.; Gutierrez Sainz, L.; Chi, P.
    Journal of Hematology & Oncology (2021)

    Fulltext@MSK | Save
  • Safety and preliminary efficacy of intratumoral cavrotolimod (AST-008), a spherical nucleic acid TLR9 agonist, in combination with pembrolizumab in patients with advanced solid tumors
    Meeting Abstract

    O'Day, S.; Perez, C.; Wise-Draper, T.; Hanna, G.; Bhatia, S.; Kelly, C.; Medina, T.; Laux, D.; Daud, A.; Chandra, S.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Reveal: Phase 1 dose-escalation study of NKTR-262, a novel TLR7/8 agonist, plus bempegaldesleukin: Local innate immune activation and systemic adaptive immune expansion for treating solid tumors
    Meeting Abstract

    Diab, A.; Curti, B.; Bilen, M.; Brohl, A.; Domingo-Musibay, E.; Borazanci, E.; Fanton, C.; Haglund, C.; Vimal, M.; Muhsin, M.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Final analysis of the phase 1 trial of NY-ESO-1-specific T-cell receptor (TCR) T-cell therapy (letetresgene autoleucel; GSK3377794) in patients with advanced synovial sarcoma (SS)
    Meeting Abstract

    D'Angelo, S.; Demetri, G.; Van Tine, B.; Druta, M.; Glod, J.; Chow, W.; Pandya, N.; Hasan, A.; Chiou, V.; Tress, J.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Modeling the efficacy of NY-ESO-1 TCR T cells (letetresgene autoleucel; GSK3377794) in patients with synovial sarcoma: Correlations of response with transduced cell kinetics and biomarkers
    Meeting Abstract

    Gyurdieva, A.; Zajic, S.; Chang, Y. F.; Houseman, E. A.; Zhong, S.; Kim, J.; Turner, D.; Johnson, L.; Eleftheriadou, I.; Tress, J.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Efficacy and immune-related adverse event associations in avelumab-treated patients
    Journal Article

    Kelly, K.; Manitz, J.; Patel, M. R.; D'Angelo, S. P.; Apolo, A. B.; Rajan, A.; Kasturi, V.; Speit, I.; Bajars, M.; Warth, J.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • PD1/PD-L1 targeting in advanced soft-tissue sarcomas: A pooled analysis of phase II trials
    Research Letter

    Italiano, A.; Bellera, C.; D'Angelo, S.
    Journal of Hematology & Oncology (2020)

    Fulltext@MSK | Save
  • Avelumab in patients with previously treated metastatic Merkel cell carcinoma: Long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial
    Journal Article

    D'Angelo, S. P.; Bhatia, S.; Brohl, A. S.; Hamid, O.; Mehnert, J. M.; Terheyden, P.; Shih, K. C.; Brownell, I.; Lebbé, C.; Lewis, K. D.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save